WO2000052468A1 - Procede et appareil permettant de reguler l'adsorption d'un echantillon liquide a travers une couche absorbante - Google Patents

Procede et appareil permettant de reguler l'adsorption d'un echantillon liquide a travers une couche absorbante Download PDF

Info

Publication number
WO2000052468A1
WO2000052468A1 PCT/US2000/005509 US0005509W WO0052468A1 WO 2000052468 A1 WO2000052468 A1 WO 2000052468A1 US 0005509 W US0005509 W US 0005509W WO 0052468 A1 WO0052468 A1 WO 0052468A1
Authority
WO
WIPO (PCT)
Prior art keywords
absorbent layer
air gap
sample
layer
glucose
Prior art date
Application number
PCT/US2000/005509
Other languages
English (en)
Inventor
Eric M. Nelson
Matthew A. Coe
Original Assignee
Lxn Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lxn Corporation filed Critical Lxn Corporation
Priority to DE60023270T priority Critical patent/DE60023270T2/de
Priority to AU38636/00A priority patent/AU3863600A/en
Priority to DK00917704T priority patent/DK1159613T3/da
Priority to EP00917704A priority patent/EP1159613B1/fr
Priority to AT00917704T priority patent/ATE307337T1/de
Publication of WO2000052468A1 publication Critical patent/WO2000052468A1/fr
Priority to HK02104286.3A priority patent/HK1042943B/zh

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/52—Use of compounds or compositions for colorimetric, spectrophotometric or fluorometric investigation, e.g. use of reagent paper and including single- and multilayer analytical elements
    • G01N33/521—Single-layer analytical elements
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/25—Chemistry: analytical and immunological testing including sample preparation
    • Y10T436/25375—Liberation or purification of sample or separation of material from a sample [e.g., filtering, centrifuging, etc.]
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/25—Chemistry: analytical and immunological testing including sample preparation
    • Y10T436/2575—Volumetric liquid transfer

Definitions

  • the present invention relates to analyzing liquid samples and more specifically to controlling the absorption of a liquid sample by an absorbent layer, thereby reducing the effect of hematocrit.
  • Test strips are widely available for conveniently analyzing liquid samples.
  • a test strip has one or more layers of absorbent material containing chemical reagents.
  • the reagents react with the components of interest in the test sample.
  • the resulting reaction can then be measured by a variety of means to yield a measurement of the components in the sample .
  • a glucose test strip can have an absorbent layer containing reagents that react with glucose present in the blood sample.
  • the reagents react with the glucose in the sample. If the reaction results in a detectable color change -- turning the absorbent layer from colorless to dark blue, for example -- the reaction can then be measured, and the amount of color produced related to the concentration of glucose in the blood sample .
  • a patient will typically use the test strip with a separate device that can measure the chemical reaction on the absorbent layer and display the patient's blood glucose concentration.
  • a separate device that can measure the chemical reaction on the absorbent layer and display the patient's blood glucose concentration.
  • One such device uses a reflectance meter, which measures reflected light of specific wavelengths, to monitor the light reflected from the surface of the absorbent layer.
  • the reflectance meter can monitor the reaction by detecting changes in the light reflected from the surface of the absorbent layer. For example, as the chemical reaction proceeds, the reflectance meter can measure an increase of blue light reflected from the absorbent layer surface.
  • the reflectance of light from the absorbent layer can be used to monitor the chemical reaction and thereby determine the glucose concentration in the blood sample.
  • a second variable that can affect the test results is the hematocrit of the patient's blood, which is a measure of the relative amount of red blood cells and plasma in a blood sample. Because the hematocrit of a patient's blood sample can vary, the absorption of the sample by the absorbent layer can vary as well, resulting in hematocrit-dependent measurements of the patient's blood glucose concentration.
  • the present invention provides a method for controlling the absorption of a liquid sample through an absorbent layer 2 by (a) providing an air gap 4c defined by the absorbent layer 2, at least one side wall 4d and a translucent window 6; and (b) applying the liquid sample to the absorbent layer on the side opposite to the air gap 2a.
  • the sample absorption is controlled by preventing the release of air from the air gap 4c.
  • the present invention also provides an apparatus for performing the method of the invention.
  • the apparatus has an absorbent layer 2, at least one side wall 4d and a translucent window 6, where the layer, walls and window define an air gap 4c.
  • Figure 1 shows an isometric view of one embodiment of the apparatus (not to scale) .
  • Figure 2 shows a cross-sectional view of one embodiment of the apparatus (not to scale) .
  • the plane of the cross-section is indicated in Figure 1.
  • Figure 3 shows an exploded isometric view of another embodiment of the apparatus including optional elements (not to scale) .
  • Second layer (optional)
  • Figure 4 compares the relative volume- dependence of test strip Model A (with air gap) and Model B (without air gap) .
  • Figure 5 compares the relative hematocrit- dependence of test strip Models A and B. DETAILED DESCRIPTION OF THE INVENTION
  • the present invention provides a method and apparatus for controlling the absorption of a liquid sample by an absorbent layer.
  • a liquid sample is applied to the application surface 2a of the absorbent layer 2, the sample is absorbed.
  • an air gap 4c is provided, defined by the viewing surface 2b on the opposite side of the absorbent layer 2, at least one side wall 4d and a surface of a translucent window 6a.
  • the "air gap” thus defined is an air-tight chamber with ambient air pressure .
  • Absorption of the liquid sample causes a slight increase in pressure within the air gap compared with the ambient pressure. This pressure increase can be explained by the decrease in effective volume of the air gap as the liquid absorbed by the layer displaces air within the layer. Because the air gap lacks an exit for the displaced air to escape, the air gap effectively prevents further sample from being absorbed by the absorbent layer.
  • Liquid samples that can be used with the invention encompass any fluid containing an analyte to be measured, for example blood, serum or plasma.
  • the term also encompasses other "human body fluids” such as sweat, tears, saliva, semen, cerebrospinal fluid, sputum, urine and cervical mucus or swabbings .
  • the term further encompasses food, environmental or industrial samples, depending on the desired application of the article, as long as they are liquid and contain an analyte for measurement.
  • the liquid sample can be analyzed for specific "analytes" of interest, which are any substances to be detected or quantitated in terms of concentration.
  • the analyte can be glucose, fructose, or other sugars, cholesterol, ketones, lipids, uric acid or specific amino acids such as phenylalanine .
  • the analyte can also be proteins, for example enzymes such as amylase, creatine kinase or alanine aminotransferase .
  • analyte can be glycated proteins, for example serum or plasma glycated protein as measured by fructosa ine, or red blood cell glycated protein as measured by glycated hemoglobin, in particular Hb Alc .
  • glycated proteins for example serum or plasma glycated protein as measured by fructosa ine, or red blood cell glycated protein as measured by glycated hemoglobin, in particular Hb Alc .
  • Other analytes are described in U.S. Patent No. 5,597,532, incorporated herein by reference.
  • the "absorbent layer” can be any material that is permeable to gas when dry and can absorb liquid, but is relatively less permeable to gas when saturated or partially saturated with liquid.
  • a particular absorbent layer is BIODYNE A 0.65 ⁇ m pore size nylon membrane (Pall Corp.; East Hills, New York).
  • the absorbent layer can contain a reagent that indicates the presence of an analyte such as glucose or fructosamine .
  • Representative absorbent layers are described in U.S. Patent No. 5,470,752, U.S. Patent No. 5,597,532 and U.S. Patent No. 5,695,949, each incorporated herein by reference.
  • a particularly useful absorbent layer contains a reagent that reacts with glucose in the liquid sample, for example a glucose oxidase/horseradish peroxidase system (Toyobo Inc.; Tokyo, Japan).
  • a glucose oxidase/horseradish peroxidase system Toyobo Inc.; Tokyo, Japan.
  • Another useful system for reacting with glucose is N-ethyl-N-2-hydroxy- 3-sulfopropyl-3, 5-dimethylaniline (MAOS) (Dojindo Laboratories; Kumamoto, Japan) and N-ethyl-N- (2-hydroxy- 3-sulfopropyl) -m-toluidine (TOOS).
  • MAOS 5-dimethylaniline
  • TOOS N-ethyl-N- (2-hydroxy- 3-sulfopropyl) -m-toluidine
  • reagents include the combination of 4-aminoantipyrene and chromotropic acid (AAP-CTA) and the combination of 3- methyl-2-benzothiazoline hydrazone hydrochloride (MBTH) and either 3-dimethylaminobenzoic acid (DMAB) or 8-anilo- 1-napthalenesulfonate (ANS) .
  • AAP-CTA 4-aminoantipyrene and chromotropic acid
  • MBTH 3- methyl-2-benzothiazoline hydrazone hydrochloride
  • DMAB 3-dimethylaminobenzoic acid
  • ANS 8-anilo- 1-napthalenesulfonate
  • the absorbent layer can be attached to a handle 4 so the user to hold the test strip without touching the absorbent layer.
  • the handle contains a hole 4c, whose inner walls 4d partially define the air gap.
  • Figure 3 shows that the side wall 4d is the inner surface of a hole 4c.
  • hole 4c is circular in Figure 3, it can also be of any shape so that there can be two or more distinct side walls forming the air gap.
  • the handle 4 can be attached to the absorbent layer 2 by any means for adhering two layers together so long as the resulting air gap is secure against the escape of air and does not occlude the viewing surface of the absorbent layer 2b along the line of sight 7.
  • the means for adhering can be acrylic-, rubber- or silicone-based adhesives.
  • a particularly useful acrylic-based adhesive layer is FAS-TAPE 8311 double- coated acrylic-based adhesive (Avery-Dennison, Inc.; Pasadena, California) .
  • Other adhesives include 3M 444 or 3M 415 double-coated adhesives (3M; Minneapolis, Minnesota) .
  • Means for adhering the sintered polymer to the solid can also include PVC plastic pipe cement, epoxy, heat staking, clamping, bolting, nailing, compression fitting and immobilization by vacuum.
  • the test strip also has a translucent window 6, which partially defines the air gap 4c by one of its surfaces 6a.
  • the "translucent window” should allow light to travel substantially along line of sight 7 to pass through the window 6 and reach the viewing surface 2b and be reflected back through window 6 so that the reflected light can be detected.
  • the window 6 may be treated to be "non-fogging" so that temperature differences in the window do not result in condensation of moisture from the ambient atmosphere.
  • the window 6 can be attached to the handle 4 by any of the means for adhering two layers discussed above.
  • an adhesive layer 3 can be used to attach the absorbent layer 2 to the handle 4, and another adhesive layer 5 can be used to attach the handle 4 to the window 6.
  • the adhesive layers 3 and 5 should have holes 3c and 5c so that they do not interfere with line of sight 7.
  • the air gap will then be defined by the viewing surface of the absorbent layer 2b, by the inner side walls of the adhesive layer 3d, of the handle 4d and of the second adhesive layer 5d, and by the surface of the window 6a.
  • Additional layers can be added to the apparatus, for example a second layer 1 for separating a whole blood sample and allowing blood plasma to reach the application surface of absorbent layer 2a.
  • a second layer 1 for separating a whole blood sample and allowing blood plasma to reach the application surface of absorbent layer 2a.
  • Such layers are well known in the art and are exemplified by the whole blood separation layers in U.S. Patent No. 5,725,774, which is incorporated by reference.
  • Model A with the air gap Model A with the air gap
  • Models B and C without an air gap Each of the models had a solid polyester handle 4 and an absorbent layer 2, which was BIODYNE A 0.65 ⁇ m pore size nylon membrane (Pall Corp.; East Hills, New York).
  • the absorbent layer was impregnated with a glucose oxidase/horseradish peroxidase system (Toyobo Inc.; Tokyo, Japan) and MAOS (N-ethyl-N-2-hydroxy-3-sulfopropyl-3, 5-dimethylaniline, sodium salt, monohydrate) (Dojindo Laboratories; Kumamoto, Japan) .
  • the handle 4 and absorbent layer 2 were attached with an adhesive layer 3, which was FAS- TAPE 8311 double-coated acrylic-based adhesive (Avery- Dennison, Inc.; Pasadena, California). These common features were modified in the three models as follows. Model A, which featured the air gap, also had a translucent window 6 of MYLAR D 4 mil-thick transparent polyester film (Dupont & Co.; Wilmington, Delaware). The film was treated by dipping in PERFECT VIEW non-aerosol anti-fog lens cleaner (Tyr Sport Inc.; Huntington Beach, California) . The film was attached to the handle 4 by an adhesive layer 5, which was the same as adhesive layer 3 above.
  • a second layer 1 was T667 or 6664 spunbonded white polyester fabric (Reemay, Inc.; Old Hickory, Tennessee) .
  • the second layer was treated with between 0.0001% and 0.1% PLURONIC polyoxypropylene polyoxyethylene block copolymer (Pragmatics Inc.; Oak Ridge, Tennessee), 8% mannitol, and 0.15% hexadimethrin, all in a 0.85% NaCl solution.
  • Model B had a second layer 1 of hydrophillic 0.0635 cm thick POREX XM-1342 sintered high density polyethylene (HDPE) treated as described for second layer 1 in Model A.
  • the layer was further treated as described in U.S. Patent Application Ser. No. 09/006,787, filed January 14, 1998.
  • Model C had a second layer 1 of T667 or 6664 spunbonded white polyester fabric (Reemay, Inc.; Old Hickory, Tennessee) .
  • the second layer was treated as described for second layer 1 in Model A.
  • EDTA tripotassium ethylenediaminetetraacetate
  • the sample was then applied to a test strip when inserted into a device containing a reflectance meter.
  • a light-emitting diode (LED) in the device directed light having a wavelength of 635 nm to the viewing surface of the absorbent layer 2b essentially along line of sight 7.
  • the reflectance of the viewing surface 2b was measured by the reflectance meter over time using a silicon photodiode, which generated an analog signal.
  • the signal was then processed by a transconductance amplifier, a synchronous detector, an analog-to-digital converter and a microprocessor. Automated processing and analysis of such detector signals is well known in the field of medical devices (see, for example, U.S. Patent 5,597,532).
  • the microprocessor then displayed the calculated values for the concentration of glucose based on a standard curve using samples having known glucose concentrations.
  • test strips featuring an air gap provide more consistent measurements than models without an air gap.
  • Model A which features the air gap
  • Models B and C which do not feature an air gap
  • the measured glucose concentration may vary, depending on the volume of the sample applied to the strip, because of wet-through.
  • the following example shows that the measurements from test strips with an air gap are less subject to variation due to changes in the volume of the sample.
  • Blood samples were prepared at about 100, 300 and 500 mg/dL as described in Example III. Samples of 3.5, 4, 5, 10, 15, 20, 30 and 40 ⁇ L of each concentration were applied to 4 strips each of models A and B, and measured using the device described in Example II.
  • Figure 4 show the average measured glucose concentrations (y-axis) using models A (three sets of solid lines) and B (three sets of dotted lines) for varying sample volumes (x-axis) and varying actual glucose concentrations (upper, middle and lower pairs of solid and dotted lines) . It is apparent that measured glucose concentrations for Model A, with the air gap, is more consistent across a range of sample volumes from 4 ⁇ l to 40 ⁇ l . In contrast, the measurements from Model B are only somewhat consistent between 10 ⁇ l and 40 ⁇ l .
  • Model A which has an air gap
  • Measurements of glucose concentration can also vary depending on the hematocrit, which is a measure of the relative amounts of red blood cells and plasma in a blood sample.
  • hematocrit is a measure of the relative amounts of red blood cells and plasma in a blood sample. The following example shows that the results from test strips with an air gap are less likely to be affected by the hematocrit of the blood sample than test strips without an air gap.
  • Blood samples were prepared at about 100, 200 and 400 mg/dL as described in Example III with hematocrits of 0 (plasma), 20, 30, 40, 50, 60 and 80%, where 80% represents the hematocrit of a sample when it is spun at 5000 rpm for 30 minutes and all plasma is removed. Sample volumes of 15 ⁇ l were applied to each of 8 strips of Models A and B each, using the device described in Example II.
  • Model A yields relatively consistent glucose measurements over the range of hematocrit values.
  • Model B can yield misleadingly low measurements as the hematocrit increases, especially when the sample contains high concentrations of glucose.
  • Model A which features the air gap
  • Model B which lacks an air gap

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Sampling And Sample Adjustment (AREA)
  • Investigating Or Analysing Materials By Optical Means (AREA)

Abstract

L'invention concerne un procédé et un appareil permettant de réguler l'absorption d'un échantillon de liquide à travers une couche absorbante (2), de réduire l'effet d'un hématocrite par application dudit échantillon sur l'un des côtés de la couche (2a) et de créer une lame d'air (4c) sur le côté opposé, l'absorption étant régulée lorsque l'air de la lame d'air ne peut se libérer.
PCT/US2000/005509 1999-03-03 2000-03-02 Procede et appareil permettant de reguler l'adsorption d'un echantillon liquide a travers une couche absorbante WO2000052468A1 (fr)

Priority Applications (6)

Application Number Priority Date Filing Date Title
DE60023270T DE60023270T2 (de) 1999-03-03 2000-03-02 Verfahren und Vorrichtung für die Kontrolle der Absorption einer flüssigen Probe durch eine absorbierende Schicht
AU38636/00A AU3863600A (en) 1999-03-03 2000-03-02 Method and apparatus for controlling the adsorption of a liquid sample through an absorbent layer
DK00917704T DK1159613T3 (da) 1999-03-03 2000-03-02 Fremgangsmåde og indretning til regulering af adsorptionen af en væskepröve gennem et absorberende lag
EP00917704A EP1159613B1 (fr) 1999-03-03 2000-03-02 Procede et appareil permettant de reguler l'adsorption d'un echantillon liquide a travers une couche absorbante
AT00917704T ATE307337T1 (de) 1999-03-03 2000-03-02 Verfahren und vorrichtung für die kontrolle von flüssig proben absorption durch eine absorbierende schicht
HK02104286.3A HK1042943B (zh) 1999-03-03 2002-06-05 透過吸收層控制液體樣本的吸收的方法及設備

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/261,707 1999-03-03
US09/261,707 US6656741B1 (en) 1999-03-03 1999-03-03 Air gap for controlling sample absorption and hematocrit dependence

Publications (1)

Publication Number Publication Date
WO2000052468A1 true WO2000052468A1 (fr) 2000-09-08

Family

ID=22994512

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2000/005509 WO2000052468A1 (fr) 1999-03-03 2000-03-02 Procede et appareil permettant de reguler l'adsorption d'un echantillon liquide a travers une couche absorbante

Country Status (9)

Country Link
US (1) US6656741B1 (fr)
EP (1) EP1159613B1 (fr)
AT (1) ATE307337T1 (fr)
AU (1) AU3863600A (fr)
DE (1) DE60023270T2 (fr)
DK (1) DK1159613T3 (fr)
ES (1) ES2251368T3 (fr)
HK (1) HK1042943B (fr)
WO (1) WO2000052468A1 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6656741B1 (en) 1999-03-03 2003-12-02 Diabetes Diagnostics, Inc. Air gap for controlling sample absorption and hematocrit dependence

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1334349B1 (fr) * 2000-10-18 2012-03-07 Art & Science, Inc. Procede de dilution de fluide et de detection d'analytes au sein d'un fluide dilue
WO2009076302A1 (fr) 2007-12-10 2009-06-18 Bayer Healthcare Llc Marqueurs de contrôle pour la détection automatique d'une solution de contrôle et procédés d'utilisation
US8105843B2 (en) * 2009-11-04 2012-01-31 Buchanan Thomas M Methods and devices to enhance sensitivity and evaluate sample adequacy and reagent reactivity in rapid lateral flow immunoassays
US9476875B2 (en) 2015-03-02 2016-10-25 Chembio Diagnostic Systems, Inc. Integrated buffer dual-path immunoassay device

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0215419A2 (fr) * 1985-09-18 1987-03-25 Miles Inc. Appareil de dosage de volumes à vide capillaire pour l'application d'un échantillon liquide sur une surface réactive
US5470752A (en) * 1994-06-29 1995-11-28 Lxn Corporation Multi-layer devices and methods of assaying for fructosamine
US5597532A (en) * 1994-10-20 1997-01-28 Connolly; James Apparatus for determining substances contained in a body fluid
US5695949A (en) * 1995-04-07 1997-12-09 Lxn Corp. Combined assay for current glucose level and intermediate or long-term glycemic control
US6024919A (en) * 1998-01-14 2000-02-15 Lxn Corporation Sonic treatment to selectively reduce the void volume of sintered polymers

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA733612B (en) 1972-10-11 1974-04-24 Merck Patent Gmbh Container for test strips
US3992158A (en) * 1973-08-16 1976-11-16 Eastman Kodak Company Integral analytical element
US4065263A (en) 1976-04-02 1977-12-27 Woodbridge Iii Richard G Analytical test strip apparatus
DE3643516A1 (de) 1986-12-19 1988-06-30 Boehringer Mannheim Gmbh Testtraeger fuer die analytische bestimmung von bestandteilen von koerperfluessigkeiten
US5419870A (en) * 1987-01-27 1995-05-30 V-Tech, Inc. Antibody testing system
EP0279574B1 (fr) 1987-02-17 1992-08-19 CMB Foodcan plc Bandelette d'analyse
US5047206A (en) 1987-03-11 1991-09-10 Wayne State University Reagent test strip
US4810470A (en) * 1987-06-19 1989-03-07 Miles Inc. Volume independent diagnostic device
US5275785A (en) * 1987-10-30 1994-01-04 Unilever Patent Holdings B.V. Test device for detecting an analyte in a liquid sample
US5104813A (en) * 1989-04-13 1992-04-14 Biotrack, Inc. Dilution and mixing cartridge
US5820826A (en) 1992-09-03 1998-10-13 Boehringer Mannheim Company Casing means for analytical test apparatus
FI92882C (fi) * 1992-12-29 1995-01-10 Medix Biochemica Ab Oy Kertakäyttöinen testiliuska ja menetelmä sen valmistamiseksi
US5725774A (en) 1995-04-07 1998-03-10 Lxn Corp. Whole blood separation method and devices using the same
US6656741B1 (en) 1999-03-03 2003-12-02 Diabetes Diagnostics, Inc. Air gap for controlling sample absorption and hematocrit dependence

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0215419A2 (fr) * 1985-09-18 1987-03-25 Miles Inc. Appareil de dosage de volumes à vide capillaire pour l'application d'un échantillon liquide sur une surface réactive
US5470752A (en) * 1994-06-29 1995-11-28 Lxn Corporation Multi-layer devices and methods of assaying for fructosamine
US5597532A (en) * 1994-10-20 1997-01-28 Connolly; James Apparatus for determining substances contained in a body fluid
US5695949A (en) * 1995-04-07 1997-12-09 Lxn Corp. Combined assay for current glucose level and intermediate or long-term glycemic control
US6024919A (en) * 1998-01-14 2000-02-15 Lxn Corporation Sonic treatment to selectively reduce the void volume of sintered polymers

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6656741B1 (en) 1999-03-03 2003-12-02 Diabetes Diagnostics, Inc. Air gap for controlling sample absorption and hematocrit dependence

Also Published As

Publication number Publication date
HK1042943B (zh) 2006-01-06
US6656741B1 (en) 2003-12-02
EP1159613B1 (fr) 2005-10-19
DE60023270T2 (de) 2006-05-24
DE60023270D1 (de) 2006-03-02
DK1159613T3 (da) 2005-12-19
HK1042943A1 (en) 2002-08-30
ATE307337T1 (de) 2005-11-15
EP1159613A1 (fr) 2001-12-05
AU3863600A (en) 2000-09-21
ES2251368T3 (es) 2006-05-01

Similar Documents

Publication Publication Date Title
US6555061B1 (en) Multi-layer reagent test strip
EP0654659B1 (fr) Dispositif d'épreuve de volume déterminé
EP0800082B1 (fr) Bandes de test pour la détermination de glucose dans le sang
EP0799896B1 (fr) Bandes de test pour la détermination de glucose dans le sang
AU722471B2 (en) Blood glucose strip having reduced sensitivity to hematocrit
KR970003312B1 (ko) 검체 결정용 최소 공정 시스템
US20040265941A1 (en) Combined assay for current glucose level and intermediate or long-term glycemic control
US20020052050A1 (en) Device for determination of an analyte a in body fluid
WO2003106968A2 (fr) Bandelette reactive pour la detection d'un analyte et procedes d'utilisation
MXPA97002503A (en) Reagent test stress to determine glucose in the san
EP0371513B1 (fr) Dispositif et méthode pour tester un échantillon liquide
EP0767909B1 (fr) Dispositifs d'analyse a couches multiples et procedes de detection de la fructosamine
US20040219691A1 (en) Test strip with clear base support layer for visual perception of a liquid sample during application
EP1159613B1 (fr) Procede et appareil permettant de reguler l'adsorption d'un echantillon liquide a travers une couche absorbante
JPH09105750A (ja) ヘマトクリット値を補正した測定方法
JP4626938B2 (ja) 試験用具及び測定方法
AU670882B2 (en) Analyte detection device and process
CN115950868A (zh) 一种抗体-斑点法进行糖化白蛋白测定的测试装置及其测试方法

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AL AM AT AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ CZ DE DE DK DK DM EE EE ES FI FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH GM KE LS MW SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
WWE Wipo information: entry into national phase

Ref document number: 2000917704

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 2000917704

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWE Wipo information: entry into national phase

Ref document number: 09914684

Country of ref document: US

WWG Wipo information: grant in national office

Ref document number: 2000917704

Country of ref document: EP